Eduardo Molina-Navarro, MD, PhD

Influence of Valve Type and Antiplatelet Regimen on Platelet Reactivity After TAVI: Subanalysis of the REAC-TAVI Trial

12/01/2020

Andres Iniguez-Romo , MD, PhD;

Victor Alfonso Jimenez-Diaz , MD, MPH;

Raúl Moreno-Gómez , MD, PhD;

Blanca Trejo-Velasco , MD;

Ignacio Cruz-Gonzalez , MD, PhD;

Antonio Tello-Montoliu , MD, PhD;

Jose Antonio Baz-Alonso , MD;

Pablo Juan Salvadores , MPH;

Rafael Romaguera , MD, PhD;

Eduardo Molina-Navarro , MD, PhD;

Emilio Paredes-Garan , MD;

Antonio De-Miguel-Castro , MD;

Guillermo Bastos-Fernandez , MD;

Alberto Ortiz-Saez , MD;

Saleta Fernandez-Barbeira , MD;

Abstract: Objectives. Ticagrelor has proven more effective than clopidogrel at attaining a maintained suppression of high platelet reactivity (HPR) in aortic stenosis patients undergoing transcatheter aortic valve implantation (TAVI). This...

Abstract: Objectives. Ticagrelor...

12/01/2020

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Eduardo Molina-Navarro, MD, PhD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products